Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Victoria R. Nachar"'
Autor:
Victoria R. Nachar, Francisco C. Savka, Sean E. McGroty, Katherine A. Donovan, Renwick C.J. Dobson, Rachel A. North, Larry J. Buckley, Andre O. Hudson
Publikováno v:
Frontiers in Microbiology, Vol 3 (2012)
The Gram-negative bacterium Verrucomicrobium spinosum has attracted interest in recent years following the sequencing and annotation of its genome. Comparative genomic analysis of V. spinosum using diaminopimelate/lysine metabolic genes from Chlamydi
Externí odkaz:
https://doaj.org/article/82120d4697d6479a8f1df8a768a3da15
Publikováno v:
Leukemia & Lymphoma. 64:407-414
Infections are an important cause of morbidity and mortality in newly diagnosed multiple myeloma (NDMM), but the real-world risk using modern induction regimens such as bortezomib, lenalidomide, and dexamethasone (RVd) is not well described. We perfo
Autor:
Tycel J. Phillips, David A Bond, Radhika Takiar, Karson J. Kump, Malathi Kandarpa, philip boonstra, Tera Lynn Mayer, Victoria R Nachar, Ryan A Wilcox, Shannon Ann Carty, Yasmin H. Karimi, zaneta nikolovska-coleska, Mark S Kaminski, Alex F Herrera, Kami Maddocks, Leslie Popplewell, Alexey V Danilov
Publikováno v:
Blood Advances.
Mantle cell lymphoma (MCL) is a rare, incurable hematological malignancy with a heterogenous presentation and clinical course. A wide variety of chemotherapy-based regimens are currently utilized in untreated patients. Several targeted or small molec
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:646-663
Patients with sickle cell disease (SCD) experience significant disease-related morbidity including multiorgan damage, chronic anemia, and debilitating pain crises. While hydroxyurea has been the primary disease modifying modality in SCD, novel therap
Autor:
David Frame, Victoria R Nachar, Shawna Kraft, Jeffrey B. Smerage, Shannon Hough, Rachel L McDevitt, Catherine Christen, Anna Brown
Publikováno v:
JCO Oncology Practice. 17:e1303-e1310
PURPOSE: Chemotherapy-induced nausea and vomiting (CINV) is a common cause of unplanned healthcare utilization. The University of Michigan Rogel Cancer Center initiated the chemotherapy remote care monitoring program (CRCMP) to proactively identify p
Autor:
Victoria R Nachar, Bernard L. Marini, Tycel Phillips, Lydia L. Benitez, Brian Bazzell, Anthony J. Perissinotti
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:295-308
Novel treatment strategies have shifted the treatment landscape for patients with diffuse large B-cell lymphoma, particularly for those with relapsed/refractory disease. However, uncertainty remains regarding the therapeutic value of these novel agen
Autor:
Catherine Christen, Morgan J Homan, Victoria R Nachar, Shawna Kraft, Justin H Reid, Lydia L. Benitez, Anna Brown, Shannon Hough, Rachel L McDevitt, David Frame
Publikováno v:
Supportive Care in Cancer. 29:6505-6510
Nausea, vomiting, constipation, and diarrhea are common cancer and cancer therapy adverse effects. Pharmacists are uniquely positioned to optimize patient symptom control and minimize excess use of hospital resources, such as emergency department vis
Publikováno v:
Journal of Onco-Nephrology. :239936932311606
Background: Bisphosphonates are the backbone of treatment for hypercalcemia of malignancy (HCM). However, concern regarding their safety in patients with renal dysfunction exists. The safety and effectiveness of bisphosphonates compared to other trea
Autor:
Victoria R Nachar, Allison J Schepers
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:939-953
Cancer-associated venous thromboembolism (VTE) is a common complication of malignancy. Patients with cancer exhibit risk factors for both recurrent VTE and major or minor bleeding. Direct oral anticoagulants (DOACs) are an attractive treatment option
Autor:
Adam C Robinson, Victoria R Nachar
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:1248-1253
Rituximab-induced acute thrombocytopenia (RIAT) is a relatively rare complication of rituximab treatment that has been infrequently reported in a number of patients with malignant lymphoma. Most commonly encountered in mantle cell lymphoma, the exten